Lu Rong, Xie Shuhong, Xu Zihao, Liu Zhen, Jiang Jia, Tang Longhai, Jin Yiming, Fu Xiaoyan
Department of Blood Screening Test, Suzhou Blood Center, Suzhou, China.
Division of Transfusion Medicine, Suzhou Blood Center, Suzhou, China.
Heliyon. 2024 Jul 30;10(15):e35431. doi: 10.1016/j.heliyon.2024.e35431. eCollection 2024 Aug 15.
The B19 virus is mainly transmitted through the respiratory tract; however, studies have shown that it can also be transmitted through blood transfusions or plasma products. This study investigated B19V antibodies, DNA, and gene typing in blood donors at a central blood station in China to evaluate the status of B19V infection.
A total of 7728 samples from Suzhou Blood Center were collected from July 2022 to April 2023. Samples were detected for the B19V DNA using real-time polymerase chain reaction. Furthermore, 893 selected samples were screened for the seroprevalence of B19V antibodies using enzyme-linked immunosorbent assay. The NS1-VP1u fragment of the B19V DNA-positive samples was amplified using nested PCR, and the sequences were determined. A B19V phylogenetic tree was constructed using neighborhood joint and maximum parsimony methods to discriminate genotypes using the NS1-VP1u sequences.
The percentages of IgG, IgM, and DNA were 19.4 %, 1.9 %, and 0.09 %, respectively. IgG positivity increased with age, and there was a significant difference among the blood groups. The IgG levels of repeat donors were greater than those of first-time donors. There were no apparent differences in the IgM levels in all the participants. Genotyping revealed that the B19 genotype was 1.
The prevalence of B19V antibodies and DNA was lower in these areas than in rest of China, indicating that the risk of B19V transmission via transfusion may be relatively low. However, during transfusion, particular attention should be paid to the B19V-susceptible populations, especially those in high-risk groups.
B19病毒主要通过呼吸道传播;然而,研究表明它也可通过输血或血浆制品传播。本研究调查了中国某中心血站献血者的B19V抗体、DNA及基因分型,以评估B19V感染状况。
2022年7月至2023年4月共采集了苏州血液中心的7728份样本。采用实时聚合酶链反应检测样本中的B19V DNA。此外,使用酶联免疫吸附测定法对893份选定样本进行B19V抗体血清流行率筛查。采用巢式PCR扩增B19V DNA阳性样本的NS1-VP1u片段,并测定序列。使用邻接法和最大简约法构建B19V系统发育树,以利用NS1-VP1u序列鉴别基因型。
IgG、IgM和DNA的阳性率分别为19.4%、1.9%和0.09%。IgG阳性率随年龄增长而升高,不同血型之间存在显著差异。多次献血者的IgG水平高于首次献血者。所有参与者的IgM水平无明显差异。基因分型显示B19基因型为1型。
这些地区B19V抗体和DNA的流行率低于中国其他地区,表明通过输血传播B19V的风险可能相对较低。然而,在输血过程中,应特别关注B19V易感人群,尤其是高危人群。